
Influenza Vaccines Global Market Report 2025
Description
Influenza Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on influenza vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for influenza vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The influenza vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Vaccine Type: Inactivated; Live Attenuated
2) By Valency: Quadrivalent; Trivalent
3) By Route Of Administration: Injection; Nasal Spray
4) By Age Group: Pediatric; Adult
5) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply; Other Distribution Channels
Subsegments:
1) By Inactivated: Trivalent Inactivated Vaccines (TIV); Quadrivalent Inactivated Vaccines (QIV)
2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV); Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on influenza vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for influenza vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The influenza vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Vaccine Type: Inactivated; Live Attenuated
2) By Valency: Quadrivalent; Trivalent
3) By Route Of Administration: Injection; Nasal Spray
4) By Age Group: Pediatric; Adult
5) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply; Other Distribution Channels
Subsegments:
1) By Inactivated: Trivalent Inactivated Vaccines (TIV); Quadrivalent Inactivated Vaccines (QIV)
2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV); Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Sanofi-Aventis LLC.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Influenza Vaccines Market Characteristics
- 3. Influenza Vaccines Market Trends And Strategies
- 4. Influenza Vaccines Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global Influenza Vaccines Growth Analysis And Strategic Analysis Framework
- 5.1. Global Influenza Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Influenza Vaccines Market Growth Rate Analysis
- 5.4. Global Influenza Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Influenza Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Influenza Vaccines Total Addressable Market (TAM)
- 6. Influenza Vaccines Market Segmentation
- 6.1. Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inactivated
- Live Attenuated
- 6.2. Global Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Quadrivalent
- Trivalent
- 6.3. Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injection
- Nasal Spray
- 6.4. Global Influenza Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pediatric
- Adult
- 6.5. Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals and Pharmacies
- Government and Institutional Supply
- Other Distribution Channels
- 6.6. Global Influenza Vaccines Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Trivalent Inactivated Vaccines (TIV)
- Quadrivalent Inactivated Vaccines (QIV)
- 6.7. Global Influenza Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Live Attenuated Influenza Vaccines (LAIV)
- Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)
- 7. Influenza Vaccines Market Regional And Country Analysis
- 7.1. Global Influenza Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Influenza Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Influenza Vaccines Market
- 8.1. Asia-Pacific Influenza Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Influenza Vaccines Market
- 9.1. China Influenza Vaccines Market Overview
- 9.2. China Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Influenza Vaccines Market
- 10.1. India Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Influenza Vaccines Market
- 11.1. Japan Influenza Vaccines Market Overview
- 11.2. Japan Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Influenza Vaccines Market
- 12.1. Australia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Influenza Vaccines Market
- 13.1. Indonesia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Influenza Vaccines Market
- 14.1. South Korea Influenza Vaccines Market Overview
- 14.2. South Korea Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Influenza Vaccines Market
- 15.1. Western Europe Influenza Vaccines Market Overview
- 15.2. Western Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Influenza Vaccines Market
- 16.1. UK Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Influenza Vaccines Market
- 17.1. Germany Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Influenza Vaccines Market
- 18.1. France Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Influenza Vaccines Market
- 19.1. Italy Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Influenza Vaccines Market
- 20.1. Spain Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Influenza Vaccines Market
- 21.1. Eastern Europe Influenza Vaccines Market Overview
- 21.2. Eastern Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Influenza Vaccines Market
- 22.1. Russia Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Influenza Vaccines Market
- 23.1. North America Influenza Vaccines Market Overview
- 23.2. North America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Influenza Vaccines Market
- 24.1. USA Influenza Vaccines Market Overview
- 24.2. USA Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Influenza Vaccines Market
- 25.1. Canada Influenza Vaccines Market Overview
- 25.2. Canada Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Influenza Vaccines Market
- 26.1. South America Influenza Vaccines Market Overview
- 26.2. South America Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Influenza Vaccines Market
- 27.1. Brazil Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Influenza Vaccines Market
- 28.1. Middle East Influenza Vaccines Market Overview
- 28.2. Middle East Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Influenza Vaccines Market
- 29.1. Africa Influenza Vaccines Market Overview
- 29.2. Africa Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Influenza Vaccines Market Competitive Landscape And Company Profiles
- 30.1. Influenza Vaccines Market Competitive Landscape
- 30.2. Influenza Vaccines Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi-Aventis LLC. Overview, Products and Services, Strategy and Financial Analysis
- 31. Influenza Vaccines Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC
- 31.2. GlaxoSmithKline plc.
- 31.3. Serum Institute of India Private Limited
- 31.4. Takeda Pharmaceutical Company Limited
- 31.5. Moderna Inc.
- 31.6. Viatris Inc.
- 31.7. CSL Limited
- 31.8. Seqirus Inc.
- 31.9. Daiichi Sankyo Company Limited
- 31.10. China National Pharmaceutical Group Corporation
- 31.11. Shanghai Fosun Pharmaceutical Group Co. Ltd.
- 31.12. Mitsubishi Tanabe Pharma Corporation
- 31.13. Shionogi & Co. Ltd.
- 31.14. Liaoning Cheng Da Biotechnology Co. Ltd.
- 31.15. Novavax AB
- 32. Global Influenza Vaccines Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Influenza Vaccines Market
- 34. Recent Developments In The Influenza Vaccines Market
- 35. Influenza Vaccines Market High Potential Countries, Segments and Strategies
- 35.1 Influenza Vaccines Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Influenza Vaccines Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Influenza Vaccines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.